Evidence map›Paper›PMID 42636464›Full record

ArticleSchizophrenia bulletin2026

Using Large Language Models to Measure Symptom Severity Scores in Patients At-Risk for Schizophrenia.

Andrew X Chen, Guillermo Horga, Sean Escola

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew X ChenDepartment of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, NY 10032, United States.ORCID 0000-0001-5303-3285
Guillermo HorgaDepartment of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, NY 10032, United States.
Sean EscolaDepartment of Psychiatry, Columbia University/New York State Psychiatric Institute, New York, NY 10032, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and hypothesisPatients who are at clinical high risk (CHR) for schizophrenia need close monitoring of their symptoms to inform appropriate treatments. The Brief Psychiatric Rating Scale (BPRS) is a validated, commonly used research tool for measuring symptoms in patients with schizophrenia and other psychotic disorders; however, it is not commonly used in clinical practice as it requires a lengthy structured interview. We hypothesized we could utilize large language models (LLMs) to predict BPRS scores from clinical interview transcripts. STUDY

designWe used LLMs to predict BPRS scores from transcripts in 409 CHR patients from the Accelerating Medicines Partnership Schizophrenia cohort. STUDY

resultsDespite the interviews not being specifically structured to measure the BPRS, the zero-shot performance of the LLM predictions compared to the true assessment (median concordance: 0.84, Intraclass Correlation Coefficient [ICC]: 0.73) approaches human inter- and intra-rater reliability. We further demonstrate that LLMs have expansive potential to improve and standardize the assessment of CHR patients via their accuracy in assessing the BPRS in foreign languages (median concordance: 0.88, ICC: 0.70), and integrating longitudinal information as one-shot or few-shot learning.

conclusionsLLMs may present a promising pathway to extract symptom severity scores from clinical interviews for improved monitoring of CHR patients.

Indexed as

Brief Psychiatric Rating ScaleLarge Language ModelsSchizophreniaSeverity of Illness IndexAdultFemaleHumansMaleReproducibility of ResultsRiskYoung AdultAIBPRSclinical high riskpsychosis

Identifiers

PMID42636464
PMCPMC13502897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.